Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New research shows comics are inspiring children to become life-long readers

Making reading a magical experience – almost one in ten children most enjoy reading comics out of all literature choices. With almost a quarter (23%) of parents and grandparents believing its top benefit is creating a habit and a love of reading. This is according to the latest research commissioned by Readly, the European leader in digital magazine and newspaper subscriptions.   Sparking curiosity and a lust for literature, the research reveals that over a third (34%) of parents and grandparents have introduced comics or fantasy magazines to their children or grandchildren.

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

FemTech on the rise in Sweden

Interest in women's health products has increased exponentially in recent years, not least among investors. The development within FemTech is progressing strongly both nationally and globally. BioStock delves into the area and lists several Swedish FemTech companies to keep an eye on.Read the full article at biostock.se: https://www.biostock.se/en/2022/11/femtech-on-the-rise-in-sweden/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Eevia Health Plc commissions new analytical equipment for analyzing anthocyanins and polyphenols

Eevia Health has commissioned a new High-Performance Liquid Chromatography (HPLC) analytical equipment from Shimadzu, which significantly increases the capacity to undertake analyses of polyphenols.The new HPLC is a Shimadzu Nexera Lite 440 bar. It has automated sampling functionality and a huge range of specialized and advanced features, which constitutes the state of the art in liquid chromatography analytics.   The HPLC-based methods are the gold standard for analyzing anthocyanins and polyphenols. It provides not only total polyphenols but breaks them down into each specific

Sanolium AB interim report, July – September 2022

Cambio constitutes the operating entities under Sanolium AB. All figures in () refer to the comparable figures from previous year. Full-year 2018 and 2019 until February 20th includes the relevant operating entities pro forma, as that is prior to the establishment of Sanolium AB.   In the report regarding Q3, 2021 there was a restatement of error. The amounts in the comparison columns are corrected numbers. Revenue in the third quarter amounted to 199.1 MSEK, representing a growth of 4.0%. Q3, July - September 2022 · Revenue amounted to 199.1 (191.4) MSEK in the third quarter,

Saab to Divest Maritime Traffic Management

Saab today announces the divestment of its Maritime Traffic Management (MTM) operation to funds advised by Agilitas Private Equity LLP (“Agilitas”) for an enterprise value of approximately 40 MEUR. MTM is a global provider of management solutions for vessel traffic, ports and terminals. Completion of the divestment is subject to certain conditions that need to be fulfilled before closing, expected to take place no later than March 2023.The divestment is in line with Saab’s strategy with increased focus on its core areas: Aeronautics, Sensors, Command & Control, Advanced Weapon Systems and

Sitowise Group Plc’s planned release schedule for financial reports in 2023 is as follows:

Sitowise Group Plc Stock Exchange Release 30 November 2022 at 10:00 a.m. EET  Sitowise Group Plc’s planned release schedule for financial reports in 2023 is as follows:  ·Financial Statements Release for 2022 on Tuesday 28 February 2023  ·Interim Report for January–March 2023 on Wednesday 10 May 2023  ·Half-year Report for January–June 2023 on Wednesday 16 August 2023  ·Interim Report for January–September 2023 on Thursday 2 November 2023   Annual Report 2022 will be released at the latest during the week beginning on 27 March 2023.  The Annual General

New Vantaa Main Police Station and Vantaa Prison to be built in Jokiniemi

SRV GROUP PLC     INVESTOR NEWS     30 NOVEMBER 2022   10:00 EEST New Vantaa Main Police Station and Vantaa Prison to be built in Jokiniemi The construction of the new Vantaa Main Police Station and Vantaa Prison is progressing in Jokiniemi, Vantaa. SRV and Senate Properties signed the agreement to implement the Vantaa Main Police Station and Vantaa Prison in June 2022. The project is being implemented under a spearhead alliance project model, and the total cost estimate is around EUR 86 million, of which the value of SRV’s contract is around EUR 77 million. EUR 17 million of the

Genova acquires additional shares in Järngrinden

Genova, which previously owns 50 percent of the shares in the property and project development company Järngrinden and has call options to acquire the remaining shares, has acquired an additional 1 percent of the shares in the company for SEK 13m from Patrik Ivarson, who consequently owns 49 percent of the company. Järngrinden will thus become a subsidiary and be consolidated in the Genova Group from and including closing on December 31, 2022.   In September 2021, Genova acquired 50 percent of the shares in Järngrinden as well as two options to acquire a further 50 percent of the

Financial Update Q3 2022: Genexis Group AB

Genexis Group AB, former Inteno Group AB, continues to perform well in Q3 and through-out 2022. This despite a general concern related to the geopolitical situation, long lead times and increased prices in the supply chain due to the ongoing disruptions driven by the global component shortages.Genexis Group proforma revenue growth September YTD is 70.5% and for the third quarter 69.5% (QoQ). All markets and Business Lines are performing in line with expectations and budget, apart from the software business IOPSYS which is YTD September lagging behind revenue budget by 9.2% but ahead of last

PRESS RELEASE: New surface heating technology from VTT controls room temperature when and where it is needed

The Warming Surfaces Company, a spinout from VTT Technical Research Centre of Finland, has developed a digital warming system that can be remotely controlled and installed into interior materials, drastically reducing the cost of heating and its carbon footprint.VTT Technical Research Centre of Finland  has announced a new spinout company –  The Warming Surfaces Company Ltd . The company brings to market a fast response digital warming surfaces technology (Digital Warmth™) that changes room heating from slowly heating air

Change in number of shares outstanding in Sectra AB during November

Linköping, Sweden – November 30, 2022 – During November, the number of shares outstanding in the medical imaging IT and cybersecurity company Sectra  (STO: SECT B) increased by 453,406 ordinary Class B shares. As of today, the final trading day of the month, the number of shares in the company totals 194,115,731 and the number of votes amounts to 312,046,871.The change was attributable to a new issue of Class C shares , which have been repurchased and  converted to Class B shares to secure the

Centers for Medicare & Medicaid Services finalizes its payment determination and sets a rate of $897 for Immunovia’s IMMray PanCan-d test

LUND (SWEDEN) – Immunovia (Nasdaq Stockholm: IMMNOV) today announced that the Centers for Medicare and Medicaid Services (CMS) has finalized their payment determination on a price of $897 for Immunovia’s IMMray PanCan-d test. The determined rate will be effective from 1st January 2023.  After a period of public comment CMS agreed with the recommendation made by the Clinical Diagnostic Laboratory Test (CDLT) Advisory Panel to crosswalk IMMray PanCan-d rate to code 81503, brand name OVA1, and set a price of $897 for Immunovia’s test.    “The CMS decision is a significant milestone

Klimator AB (publ)

Interim Report 3, July – September 2022Third quarter July 1 – September 30, 2022 Group · Operating income amounted to SEK 4,018K (SEK 2,025K) · Operating profit amounted to SEK -7,109K (SEK -7,693K) · Net profit after income taxes amounted to SEK -7,357K (SEK -7,722K) · Net profit per share after income taxes amounted to SEK -0.47 (SEK -0.58)       (Amounts within parentheses refer to the corresponding figures for the same period the prior year) Nine months January 1 – September 30, 2022 Group · Operating income amounted to SEK 13,543K (SEK 9,851K) ·

Wyld Networks’ Interim Report Q3 2022: Wyld Prepares For Commercial Launch In December

Wyld signs new launch partners, expands LEO satellite coverage and prepares for commercial launch on 8[th] DecemberCEO Alastair Williamson: “In Q3, we have been working to ensure the launch of our service on December 8th 2022. Wyld have signed over 40 alliances with launch partners from a wide array of sectors, and built a formidable purchase order book for both Wyld Connect units along with data service orders, that will continue to convert to revenue for the business in 2023. Wyld have signed a commercial agreement with Lacuna Space to increase satellite connectivity capacity

Omnicar Holding AB Q3 2022 report

Please find attached our Q3 2022 report. Omnicar remains on track with its growth and expected traction for OmnicarService in 2022. · OmniCarService showed growth in third quarter of 2022 with revenue increased by 15% compared to previous quarter of 2022 and 88% YoY. The lower sale from OmnicarSale compared to our expectations has had a negative effect on our 3Q22 result. We expect this to continue in 4Q22, however, we are convinced that the decision to put the sales activities on hold as previously announced will have a positive effect already in 1Q23 and on our primary

Stayble Therapeutics presents at ProHearings Capital Market Day on December 1 2022

On Thursday, December 1, Stayble Therapeutics AB ("Stayble" or the "Company") will participate in ProHearing's investor event. The Company's CEO, Andreas Gerward, will give an investor presentation and answer questions in a moderated Q&A session following the presentation.The presentation and Q&A session will be broadcast live via a link at www.prohearings.com, where you can also register to attend the event in person. Questions can be sent to the moderator by emailing info@prohearings.com. After the event, the presentation will be available on our website https://staybletherapeutics.com/.

Restructuring charge for global cost and efficiency programme

As communicated previously, the H&M group has initiated a global programme to reduce costs and further improve efficiency in the business. The programme relates to administrative and overhead costs, and also entails reducing the workforce by around 1,500 positions. Overall, it is estimated that this will provide annual savings of around SEK 2 billion which are expected to become visible in the second half of 2023. The programme is expected to result in a restructuring charge of just over SEK 800 million in the fourth quarter of 2022. “The cost and efficiency programme that we have

MTG’s Game Makers Day 2022 is live streaming today

London, 30 November 2022 – Modern Times Group MTG AB is today hosting a Game Makers Day for investors, analysts and other stakeholders. The live stream for the event will commence at 10.30 CET / 09.30 GMT.Please go to https://www.mtg.com/cmd/game-makers-day-2022/ to watch the live stream. Viewers will also have an opportunity to ask questions digitally during the day. All materials, including video recordings of the presentations, will be made available on MTG’s web page after the event.

HC Andersen Capital Event 30/11: Meet the top management in Qlife Holding

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.QLIFE HOLDING – PRESENTATION OF Q3 INTERIM REPORT 2022 Qlife Holding has recently published their interim report for Q3 2022. Revenue in the period amounted to kSEK 1,967 (5,871). Revenue includes sales of Egoo.Health devices and capsules for the device. The company has continued decline in test activity following the end of Covid travel restrictions has led to a decline in revenue in line with expectations from the company. EBITDA for the

Leading Baltic pharmaceutical manufacturer Grindeks chooses Zalaris to implement SAP SuccessFactors solutions

Zalaris, the provider of payroll and HR solutions that simplify work life and support creating sustainable businesses, are proud to announce the partnership with Grindeks to modernise and digitalise HR processes with SAP SuccessFactors solutions.Grindeks  produces high quality active pharmaceutical ingredients and final dosage forms, ensuring patients and partners worldwide with safe and modern products.  As Grindeks is driving towards HR process digitalisation using SAP, the partnership with Zalaris was a logical next step for the company, considering Zalaris’

Dentalum Operations AB (publ) Q3 report

Dentalum Operations AB (publ) publishes the interim report for the third quarter 2022Third quarter, July - September 2022 · Operating revenue amounted to SEK 89.7 million (53.6) · EBITDA amounted to SEK 13.8 million (9.9) · Certain clinics have performed in excess of forecast and as a consequence Dentalum has revaluated the contingent liabilities related to earn-outs.  The total effect of the revaluation in the profit and loss statement accumulated to SEK -54.3 million (0). · Net loss amounted to SEK -59.7 million (-2.8). · Operating cash flow amounted to SEK 4.0 million (6.

Q4 2022: THE TRANSFORMATION PLAN PROGRESSES AND IMPORTANT GOALS ARE REACHED

During the fourth quarter, we have noted the highest number of passengers since the pandemic started. Our capacity increased 15% compared with the third quarter and grew 52% year-over-year. We are also proud to see that our Customer Satisfaction Index is increasing, meaning that not only our valued customers are continuing to choose us, but it also indicates that they are appreciating our product offering. Overall underlying demand for travel was healthy during the summer and the trend continued through the fourth quarter, with an expected minor dip in October. We are now entering the

AstraZeneca announces sale of West Chester site

30 November 2022 07:05 GMT AstraZeneca announces sale of its West Chester, Ohio (US) manufacturing site National Resilience, Inc. to expand site and support future growth of its medicines manufacturing capabilities AstraZeneca today announces the sale of its West Chester site in Ohio, US, to National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines. Andrew Wirths, Senior Vice President, Americas Supply Region, AstraZeneca, said: "As part of our long-term strategy to ensure our global supply network

There are no items matching the current filter
There are no more items matching the current filter
Back to top